Homology Medicines, Inc. Business Operations Contracts & Agreements
11 Contracts & Agreements
- Collaboration Agreements (6 contracts)
- Indemnification Agreements (3)
- Supply Agreements (1)
- Termination Agreements (1)
- Form of Indemnification Agreement for Directors of Q32 Bio Inc (Filed With SEC on March 27, 2024)
- Form of Indemnification Agreement for Officers of Q32 Bio Inc (Filed With SEC on March 27, 2024)
- Termination Agreement, dated November 10, 2023, between Q32 Bio Inc. and Horizon Therapeutics DAC (Filed With SEC on December 18, 2023)
- Collaboration and Option Agreement, dated August 12, 2022, by and between Q32 Bio Inc. and Horizon Therapeutics Ireland DAC (Filed With SEC on December 18, 2023)
- Manufacturing and Supply Agreement, dated March 10, 2022, by and among Homology Medicines, Inc., Roadrunner Solutions LLC and, solely for purposes of Section 2.3(b)(iii) thereof,... (Filed With SEC on March 23, 2022)
- Second Amendment to Collaboration and License Agreement, dated October 30, 2020, between Homology Medicines, Inc. and Novartis Institutes for BioMedical Research, Inc (Filed With SEC on November 9, 2020)
- Amendment to Collaboration and License Agreement, dated December 17, 2018, between Homology Medicines, Inc. and Novartis Institutes for BioMedical Research, Inc (Filed With SEC on August 10, 2020)
- Collaboration and License Agreement, dated November 6, 2017, between the Registrant and Novartis Institutes for BioMedical Research, Inc (Filed With SEC on March 23, 2018)
- Collaboration and License Agreement, dated November 6, 2017, between the Registrant and Novartis Institutes for BioMedical Research, Inc (Filed With SEC on March 19, 2018)
- Form of Indemnification Agreement for Directors and Officers (Filed With SEC on March 19, 2018)
- Collaboration and License Agreement, dated November 6, 2017, between the Registrant and Novartis Institutes for BioMedical Research, Inc (Filed With SEC on March 2, 2018)
